DAVID KIRSKE Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for DAVID KIRSKE.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of DAVID KIRSKE. DAVID KIRSKE is a EVP, Chief Financial Officer in CTI BIOPHARMA CORP ($CTIC) and a See Remarks in CTI BIOPHARMA CORP ($CTIC).
Address: C/O CTI BIOPHARMA CORP. 3101 WESTERN AVE., SUITE 600 SEATTLE 98121 WA
Companies in which DAVID KIRSKE is an Insider
CTI BIOPHARMA CORP
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DAVID KIRSKE: EVP, Chief Financial Officer, See Remarks
Holdings: 3,798 shares
Current Value: $17,737
Latest Transaction: Mar 12 2021
$CTIC Market Capitalization: $129.36M
$CTIC Previous Close: $4.67
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of DAVID KIRSKE
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 12 2021 | CTIC | CTI BIOPHARMA CORP | KIRSKE DAVID | EVP, Chief Financia ... | Option Exercise | S | 3.30 | 200,000 | 660,000 | 200,000 | |
| Mar 12 2021 | CTIC | CTI BIOPHARMA CORP | KIRSKE DAVID | EVP, Chief Financia ... | Grant | A | 0.98 | 3,798 | 3,722 | 3,798 | 0 to 3.8 K |
| Mar 13 2020 | CTIC | CTI BIOPHARMA CORP | KIRSKE DAVID | EVP, Chief Financia ... | Option Exercise | A | 1.00 | 350,000 | 350,000 | 350,000 | |
| Feb 21 2019 | CTIC | CTI BIOPHARMA CORP | KIRSKE DAVID | EVP, Chief Financia ... | Option Exercise | A | 0.95 | 500,000 | 474,450 | 500,000 | |
| Sep 20 2018 | CTIC | CTI BIOPHARMA CORP | KIRSKE DAVID | EVP, Chief Financia ... | Option Exercise | A | 1.88 | 125,000 | 235,000 | 125,000 | |
| May 17 2018 | CTIC | CTI BIOPHARMA CORP | KIRSKE DAVID | EVP, Chief Financia ... | Option Exercise | A | 4.14 | 83,396 | 345,259 | 83,396 | |
| Oct 03 2017 | CTIC | CTI BIOPHARMA CORP | KIRSKE DAVID | EVP, Chief Financia ... | Option Exercise | A | 3.19 | 315,000 | 1,004,850 | 315,000 |